Supplementary data for Pisani et al: COVID-19 may expand the market for substandard and fake medicines

These data are compiled from UN Comtrade (global exports of raw materials for antibiotic production); United States Food and Drug Administration (shortages database); UK Pharmaceutical Services Negotiating Committee (price concessions); UK Department of Health and Social Care (ban on medicine exports) and Central Drugs Standard Control Organisation, India (post-market surveillance).